STUDY DESIGN: This report documents cerebrospinal fluid leakage after application of anti-adhesion barrier gel in a single-surgeon clinical series of 27 patients treated with ADCON-L (Gliatech, Cleveland, OH) during surgery. OBJECTIVE: To discuss a heretofore unreported postoperative complication when using an anti-adhesion barrier gel for lumbar spinal surgery. SUMMARY OF BACKGROUND DATA: Anti-adhesion barrier gel has been touted as a beneficial adjunct to lumbar surgery. No previous report has been identified that documents the complication encountered in this series. METHODS: During the time that ADCON-L was used, in a 9-month period, all spinal surgeries were reviewed, and those cases where ADCON-L was used were documented. The reports of all surgeries then were reviewed for complications during surgery, and clinical follow-up information was obtained. RESULTS: Five of 27 cases receiving ADCON-L during surgery developed cerebrospinal fluid leakage. Three of these patients required reoperation. CONCLUSION: The excessive rate of cerebrospinal fluid leakage after the use of ADCON-L is significant, and the morbidity associated with its use outweighs the potential benefit of the product.
STUDY DESIGN: This report documents cerebrospinal fluid leakage after application of anti-adhesion barrier gel in a single-surgeon clinical series of 27 patients treated with ADCON-L (Gliatech, Cleveland, OH) during surgery. OBJECTIVE: To discuss a heretofore unreported postoperative complication when using an anti-adhesion barrier gel for lumbar spinal surgery. SUMMARY OF BACKGROUND DATA: Anti-adhesion barrier gel has been touted as a beneficial adjunct to lumbar surgery. No previous report has been identified that documents the complication encountered in this series. METHODS: During the time that ADCON-L was used, in a 9-month period, all spinal surgeries were reviewed, and those cases where ADCON-L was used were documented. The reports of all surgeries then were reviewed for complications during surgery, and clinical follow-up information was obtained. RESULTS: Five of 27 cases receiving ADCON-L during surgery developed cerebrospinal fluid leakage. Three of these patients required reoperation. CONCLUSION: The excessive rate of cerebrospinal fluid leakage after the use of ADCON-L is significant, and the morbidity associated with its use outweighs the potential benefit of the product.
Authors: Claudia Cencetti; Davide Bellini; Cristina Longinotti; Andrea Martinelli; Pietro Matricardi Journal: J Mater Sci Mater Med Date: 2011-01-08 Impact factor: 3.896
Authors: Gerd M Ivanic; Peter T Pink; Frank Schneider; Markus Stuecker; Nicolaus C Homann; Klaus W Preidler Journal: Eur Spine J Date: 2006-06-09 Impact factor: 3.134
Authors: Katarina Rönnberg; B Lind; B Zoega; G Gadeholt-Göthlin; K Halldin; M Gellerstedt; H Brisby Journal: Eur Spine J Date: 2008-10-23 Impact factor: 3.134